AIM logo
Subscribe

AI Genomics Startup Nabs $25 Million to promote health equity

The company has set the ambitious goal of sequencing the genetic diversity of 10 million people this decade.
“Galatea Bio envisions a future where healthcare is accessible to all and tailored to each individual’s genetic makeup and predicted future disease trajectory,” Dr. Carlos D. Bustamante, CEO & Founder at Galatea Bio Founded in 2021 by renowned population geneticist Dr. Bustamante, Galatea Bio is on a mission to tackle one of genomics' most pressing challenges: creating comprehensive, predictive datasets that better represent historically underrepresented global populations. By advancing inclusive genomic research, the company aims to enhance our understanding of human genetics, improve healthcare outcomes, and drive personalized medicine for all. The study of the complete set of genetic material (DNA) within the genomes of organisms, including humans, animals, plants, and m
Subscribe or log in to Continue Reading

Uncompromising innovation. Timeless influence. Your support powers the future of independent tech journalism.

Subscribe

Already have an account? Sign In.

📣 Want to advertise in AIM Media House? Book here >

Picture of Upasana Banerjee
Upasana Banerjee
Upasana is a Content Strategist with AIM Research. Prior to her role at AIM, she worked as a journalist and social media editor, and holds a strong interest for global politics and international relations. Reach out to her at: upasana.banerjee@analyticsindiamag.com
25 July 2025 | 583 Park Avenue, New York
MachineCon 2025
The Biggest Exclusive Gathering of CDOs & AI Leaders In United States
View Event >>
Most Popular
From Enterprise AI
From AI Startups
From Leadership

Subscribe to our Newsletter: AIM Research’s most stimulating intellectual contributions on matters molding the future of AI and Data.

Boston CDO Vision-Popup